United Therapeutics
UTHR
#1107
Rank
C$29.15 B
Marketcap
C$644.63
Share price
-1.50%
Change (1 day)
21.03%
Change (1 year)

EPS for United Therapeutics (UTHR)

EPS in 2025 (TTM): C$40.10

According to United Therapeutics's latest financial reports the company's current EPS (TTM) is C$39.53. In 2024 the company made an earnings per share (EPS) of C$36.67 an increase over its 2023 EPS that were of C$29.20.

EPS history for United Therapeutics from 2013 to 2025

Annual EPS

Year EPS Change
2025 (TTM)C$40.109.35%
2024C$36.6725.59%
2023C$29.2031.54%
2022C$22.2051.18%
2021C$14.68-9.1%
2020C$16.15-581.4%
2019C-$3.36-117.79%
2018C$18.8642.11%
2017C$13.27-40.93%
2016C$22.4613.45%
2015C$19.80104.29%
2014C$9.69100.29%
2013C$4.84

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Eli Lilly
LLY
C$28.45-28.03%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
C$9.04-77.13%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
C$0.87-97.79%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Pfizer
PFE
C$2.38-93.97%๐Ÿ‡บ๐Ÿ‡ธ USA
Baxter
BAX
C-$0.92-102.31%๐Ÿ‡บ๐Ÿ‡ธ USA
Cytokinetics
CYTK
C-$8.72-122.06%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
C$4.99-87.39%๐Ÿ‡ฌ๐Ÿ‡ง UK
Cardinal Health
CAH
C$9.23-76.64%๐Ÿ‡บ๐Ÿ‡ธ USA